Walgreens believes it can provide expertise to GuoDa and support its growth ambitions.
“We are very pleased to become a strategic investor in GuoDa,” said Walgreens Executive Vice Chairman and CEO Stefano Pessina. “It is China’s leading pharmacy chain and we believe that we can positively contribute to its continued successful development with our global pharmacy expertise. We have had a presence in China for around 10 years, initially through Alliance Boots, and we are excited about the opportunity to further invest in the country’s fast growing retail pharmacy sector.”
GuoDa, which operates more than 3,500 retail pharmacies, is a subsidiary of China National Accord Medicines.
More articles on healthcare finance:
Insider selling: Interim CEO unloads $35M in Cerner stock
North Philadelphia Health System CEO to resign as part of cost-cutting plan
Los Angeles hospital closes, lays off all 638 employees
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
